Lord, Abbett & Co’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
EIG
Lord, Abbett & Co's TWST Position: Q2 2026 in Review
Lord, Abbett & Co increased its Twist Bioscience (TWST) stake by 200% in Q2 2026, buying an estimated $13M and bringing the position to 299,256 shares worth $30.8M. The position accounts for 0.09% of the portfolio, ranked #242.
Lord, Abbett & Co first reported a position in TWST in Q2 2019 and has held it in 15 quarters since. The position peaked at $62.3M in Q4 2020. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.
- Lord, Abbett & Co held 299,256 shares of Twist Bioscience worth $30.8M as of Q2 2026.
- Lord, Abbett & Co bought 199,626 Twist Bioscience shares in Q2 2026, an estimated $13M.
- Twist Bioscience made up 0.09% of Lord, Abbett & Co's portfolio in Q2 2026, its #242 holding.
- Lord, Abbett & Co first reported a position in Twist Bioscience in Q2 2019 and has held it in 15 quarters since.
- Lord, Abbett & Co's Twist Bioscience position peaked at $62.3M in Q4 2020.
- 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.
Based on Lord, Abbett & Co's 13F filing for Q2 2026, filed 14 Aug 2026.